NCT01732068View on ClinicalTrials.gov

Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
InfertilityPoor Ovarian Response
Interventions
DRUG

Triptorelin

Triptorelin 0.1 mg/1 ml solution daily from day 1 or 2 of the cycle onwards

DRUG

Corifollitropin alfa

Corifollitropin alfa 150μg (single dose) on day 2 or 3 of the cycle

DRUG

hpHMG

300IU hMG daily from day 7 following Corifollitropin alfa until the day of ovulation triggering

Trial Locations (1)

1090

Centre for Reproductive Medicine UZ Brussel, Brussels

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER

NCT01732068 - Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol | Biotech Hunter | Biotech Hunter